Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
Emmanouil Fokas; Philipp Ströbel; Rainer Fietkau; Michael Ghadimi; Torsten Liersch; Gerhard G. Grabenbauer; Arndt Hartmann; Marco Kaufmann; Rolf Sauer; Ullrich Graeven; Hans Hoffmanns; Hans-Rudolf Raab; Torsten Hothorn; Christian Wittekind; Claus Rödel
Author Information: Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany (EF, CR); Institute of Pathology (PS) and Department of General, Visceral and Pediatric Surgery (MG, TL), University Medical Center Göttingen, Göttingen, Germany; Department of Radiation Therapy (RF, RS) and Institute of Pathology (AH), University of Erlangen-Nürnberg, Nürnberg, Germany (RF, RS); Department of Radiation Oncology and Radiotherapy, DiaCura and Klinikum Coburg, Coburg, Germany (GGG); Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland (MK, TH); Department of Hematology/Oncology and Gastroenterology (UG) and Department of Radiation Oncology (HH), Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany; Department of General and Visceral Surgery, University of Oldenburg, Oldenburg, Germany (HRR); Institute of Pathology, University of Leipzig, Leipzig, Germany (CW); German Cancer Research Center (DKFZ), Heidelberg, Germany (EF, CR); German Cancer Consortium (DKTK), partner site: Frankfurt/Mainz, Heidelberg, Germany (EF, CR).
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.